Neuronal ceroid lipofuscinosis
MONDO:0016295A group of inherited progressive degenerative brain diseases characterized clinically by a decline of mental and other capacities, epilepsy, and vision loss through retinal degeneration, and histopathologically by intracellular accumulation of an autofluorescent material, ceroid lipofuscin, in the neuronal cells in the brain and in the retina.
Also known as: NCL, ceroid lipofuscinoses, neuronal ceroid lipofuscinosis
23 clinical trials for this condition and its sub-types, 6 tagged with Neuronal ceroid lipofuscinosis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Neuronal ceroid lipofuscinosis
-
Neuronal ceroid lipofuscinosis 3 12 trials
2 sub-types
-
Neuronal ceroid lipofuscinosis 2 8 trials
3 sub-types
-
8 sub-types
- Juvenile neuronal ceroid lipofuscinosis 1 0 trials
- Juvenile neuronal ceroid lipofuscinosis 10 0 trials
- Juvenile neuronal ceroid lipofuscinosis 2 0 trials
- Juvenile neuronal ceroid lipofuscinosis 3 0 trials
- Juvenile neuronal ceroid lipofuscinosis 5 0 trials
- Juvenile neuronal ceroid lipofuscinosis 6 0 trials
- Neuronal ceroid lipofuscinosis 9 0 trials
- Parkinsonism due to ATP13A2 deficiency 0 trials
-
Ceroid lipofuscinosis, neuronal, 6A 4 trials
2 sub-types
-
Neuronal ceroid lipofuscinosis 7 2 trials
-
Neuronal ceroid lipofuscinosis 8 1 trial · 2 incl. sub-types
2 sub-types
-
Neuronal ceroid lipofuscinosis 1 1 trial
4 sub-types
-
3 sub-types
-
Neuronal ceroid lipofuscinosis 5 1 trial
3 sub-types
-
Adult neuronal ceroid lipofuscinosis 0 trials
5 sub-types
- Adult neuronal ceroid lipofuscinosis 1 0 trials
- Adult neuronal ceroid lipofuscinosis 5 0 trials
- Ceroid lipofuscinosis, neuronal, 4 (Kufs type) 0 trials
- Neuronal ceroid lipofuscinosis 11 0 trials
- Neuronal ceroid lipofuscinosis 13 0 trials
-
2 sub-types
-
Rare brain disease study seeks to unlock mysteries of atypical TPP1 deficiency
Knowledge-focused OngoingThis study follows 5 people with a rare, late-onset form of TPP1 deficiency (a brain disease) to track how their symptoms change over time. Researchers will use tests like brain scans, eye exams, and movement assessments to better understand the condition. The goal is to gather i…
Sponsor: Children's Hospital of Orange County • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
New study aims to measure how CLN2 disease affects Children's development
Knowledge-focused By invitation onlyThis study looks at how children with CLN2 Batten disease develop over time, including their thinking, language, and motor skills. Researchers will compare children who receive treatment (cerliponase alfa) with those who do not. The goal is to find better ways to measure the dise…
Sponsor: Jessica Scherr • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC